Author | Howard A. "Skip" Burris, MD | OncLive

Author | Howard A. "Skip" Burris, MD

Articles

Howard "Skip" Burris, MD: A Passion for Befriending Patients and Always Being Kind

November 01, 2019

Podcast

Howard A. Burris, MD, also known as "Skip," of Sarah Cannon Research Institute, discussed how he wound up in the oncology space, his passion for getting to know and helping his patients, and some proud moments throughout his monumental career.

Dr. Burris on Updated MONALEESA-2 Trial Results for HR+ Breast Cancer

December 10, 2016

Video

Howard A. "Skip" Burris, MD, president of Clinical Operations and chief medical officer at Sarah Cannon Research Institute, discusses updated findings from the MONALEESA-2 trial, which explored first-line treatment with ribociclib plus letrozole in patients with hormone receptor (HR)-positive, HER2-negative breast cancer.

Dr. Burris on Remaining Challenges in Treating HER2+ Breast Cancer

October 07, 2016

Video

Howard A. “Skip” Burris, MD, president of Clinical Operations and chief medical officer at Sarah Cannon Research Institute, a 2014 Giant of Cancer Care in Drug Development, discusses the biggest remaining challenges in treating patients with HER2-positive breast cancer.

x